Targeted Drug Therapies: Beyond Blood Counts and Chemistries

Area of Science:

• Oncology
• Pharmacotherapy
• Clinical Chemistry

Background:

• The field of oncology pharmacotherapy has seen rapid advancement with novel targeted therapies.
• These targeted therapies, while effective, are associated with numerous unintended side effects.
• Effective management of these side effects necessitates a strong understanding of laboratory monitoring parameters.

Purpose of the Study:

• To highlight the critical role of laboratory monitoring in managing side effects of novel oncology pharmacotherapies.
• To emphasize the need for updated knowledge among healthcare professionals regarding these monitoring requirements.

Main Methods:

• Review of current literature on targeted oncology therapies and their associated toxicities.
• Analysis of established and emerging laboratory monitoring guidelines for common side effects.
• Synthesis of information to provide a practical overview for clinicians.

Main Results:

• Identification of key laboratory tests required for monitoring specific targeted therapies.
• Correlation of common side effects with specific laboratory abnormalities.
• Demonstration of how laboratory monitoring guides therapeutic adjustments and toxicity management.

Conclusions:

• Laboratory monitoring is indispensable for the safe and effective use of novel oncology pharmacotherapies.
• Continuous education on laboratory monitoring is crucial for oncologists and pharmacists.
• Proactive laboratory monitoring can significantly improve patient outcomes and reduce treatment-related morbidity.